Discovery of evocalcet, a next-generation calcium-sensing receptor agonist for the treatment of hyperparathyroidism-Reference-Cited by-同舟云学术

Discovery of evocalcet, a next-generation calcium-sensing receptor agonist for the treatment of hyperparathyroidism

Published:2018-06 Issue:11 Volume:28 Page:2055-2060
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Miyazaki Hiroshi,Ikeda Yousuke,Sakurai Osamu,Miyake Tsutomu,Tsubota Rie,Okabe Jyunko,Kuroda Masataka,Hisada Yutaka,Yanagida Tetsuya,Yoneda Hikaru,Tsukumo Yukihito,Tokunaga Shin,Kawata Takehisa,Ohashi Rikiya,Fukuda Hajime,Kojima Koki,Kannami Ayako,Kifuji Takayuki,Sato Naoya,Idei Akiko,Iguchi Taku,Sakairi Tetsuya,Moritani Yasunori

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference29 articles.

1. Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options;Cunningham;Clin J Am Soc Nephrol,2011

2. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS);Tentori;Am J Kidney Dis,2008

3. Serum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients;Taniguchi;Ther Apher Dial,2013

4. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?;Raggi;J Am Coll Cardiol,2002

5. High rates of death and hospitalization follow bone fracture among hemodialysis patients;Tentori;Kidney Int,2014

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A spirosilane ligand induced highly enantioselective Rh-catalyzed cycloisomerization of 1,6-enynes;Green Synthesis and Catalysis;2024-08

2. Silicon-Rhodamine Functionalized Evocalcet Probes Potently and Selectively Label Calcium Sensing Receptors In Vitro, In Vivo, and Ex Vivo;ACS Pharmacology & Translational Science;2024-04-25

3. Long-term treatment of evocalcet in hemodialysis patients with secondary hyperparathyroidism: a five-year prospective cohort study in 147 Japanese patients;Renal Replacement Therapy;2024-03-05

4. One-Pot Sequential Two-Step Photo-Biocatalytic Deracemization of sec-Alcohols Combining Photocatalytic Oxidation and Bioreduction;ACS Catalysis;2024-01-19

5. Rational design of imine reductase for asymmetric synthesis of α-methyl-benzylaminonitrogen heterocycles;Molecular Catalysis;2024-01